Wikidata

(Q44400153)

English

Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment

scientific article published in April 2003

In more languages

Statements

title
Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12690306
retrieved
2 December 2017
author name string
Daniel A Vorobiof
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12690306
retrieved
2 December 2017
Rabia Mahomed
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12690306
retrieved
2 December 2017
Margaret Karime
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12690306
retrieved
2 December 2017
publication date
1 April 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12690306
retrieved
2 December 2017
page(s)
201-203
1 reference
stated in
Europe PubMed Central
PubMed ID
12690306
retrieved
2 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44400153&oldid=2020999166"